Jane Street Group, LLC Vigil Neuroscience, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.51 - $4.66 $156,508 - $290,569
62,354 New
62,354 $249,000
Q4 2023

Feb 14, 2024
BUY
$2.97 - $8.6 $30,228 - $87,530
10,178 New
10,178 $34,000
Q1 2023

May 15, 2023
BUY
$8.77 - $12.7 $238,403 - $345,236
27,184 New
27,184 $266,000

Others Institutions Holding VIGL

# of Institutions
53
Shares Held
27.9M
Call Options Held
0
Put Options Held
0
View Full List

About Vigil Neuroscience, Inc.

VIGL Quotes by TradingView
  • Ticker VIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,268,600
  • Market Cap $48.1M
  • Description
  • Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...
More about VIGL
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email